Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Beckman

Showing results (181-190 of 398) with videos related to

Pageof 40
Sort By:
Contemporary Clinical Trials|March 26, 2017
How many tumor indications should be initially screened in development of next generation immunotherapies?Cong Chen, Qiqi Deng, Linchen He, et al.
Statistics in Biopharmaceutical Research|April 3, 2023
Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials TomorrowGianna McMillan, Cristiana Mayer, Rui Tang, et al.
Paediatric Drugs|October 14, 2022
Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small PatientsRobert A Beckman, Zoran Antonijevic, Mercedeh Ghadessi, et al.
Circulation Research|January 12, 2002
Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humansJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Placenta|April 1, 1994
Amino acid requirements in the early post-implantation rat conceptusT R Koszalka, C L Andrew, R L Brent, et al.
Heart (British Cardiac Society)|January 7, 2018
Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgeryNathaniel R Smilowitz, Navdeep Gupta, Yu Guo, et al.
Journal of the American Heart Association|November 8, 2019
Discretionary Thrombophilia Test Acquisition and Outcomes in Patients With Venous Thromboembolism in a Real-World Clinical SettingPatrick M Kozak, Meng Xu, Eric Farber-Eger, et al.
Journal of Theoretical Biology|May 12, 2019
Modelling bistable tumour population dynamics to design effective treatment strategiesAndrei R Akhmetzhanov, Jong Wook Kim, Ryan Sullivan, et al.
Statistical Methods in Medical Research|December 20, 2017
Optimized adaptive enrichment designsThomas Ondra, Sebastian Jobjörnsson, Robert A Beckman, et al.
Circulation Research|June 10, 2021
Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) InhibitorsMatthew R Fleming, Ling Xiao, Klarissa D Jackson, et al.
Pageof 40

Showing results (181-190 of 398) with videos related to

Sort By:
Pageof 40
Contemporary Clinical Trials|March 26, 2017
How many tumor indications should be initially screened in development of next generation immunotherapies?Cong Chen, Qiqi Deng, Linchen He, et al.
Statistics in Biopharmaceutical Research|April 3, 2023
Planning for the Next Pandemic: Ethics and Innovation Today for Improved Clinical Trials TomorrowGianna McMillan, Cristiana Mayer, Rui Tang, et al.
Paediatric Drugs|October 14, 2022
Innovations in Clinical Development in Rare Diseases of Children and Adults: Small Populations and/or Small PatientsRobert A Beckman, Zoran Antonijevic, Mercedeh Ghadessi, et al.
Circulation Research|January 12, 2002
Inhibition of protein kinase Cbeta prevents impaired endothelium-dependent vasodilation caused by hyperglycemia in humansJoshua A Beckman, Allison B Goldfine, Mary Beth Gordon, et al.
Placenta|April 1, 1994
Amino acid requirements in the early post-implantation rat conceptusT R Koszalka, C L Andrew, R L Brent, et al.
Heart (British Cardiac Society)|January 7, 2018
Trends in cardiovascular risk factor and disease prevalence in patients undergoing non-cardiac surgeryNathaniel R Smilowitz, Navdeep Gupta, Yu Guo, et al.
Journal of the American Heart Association|November 8, 2019
Discretionary Thrombophilia Test Acquisition and Outcomes in Patients With Venous Thromboembolism in a Real-World Clinical SettingPatrick M Kozak, Meng Xu, Eric Farber-Eger, et al.
Journal of Theoretical Biology|May 12, 2019
Modelling bistable tumour population dynamics to design effective treatment strategiesAndrei R Akhmetzhanov, Jong Wook Kim, Ryan Sullivan, et al.
Statistical Methods in Medical Research|December 20, 2017
Optimized adaptive enrichment designsThomas Ondra, Sebastian Jobjörnsson, Robert A Beckman, et al.
Circulation Research|June 10, 2021
Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) InhibitorsMatthew R Fleming, Ling Xiao, Klarissa D Jackson, et al.
Pageof 40